Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
On The Fly
Fly Intel: After-Hours Movers » 17:52
04/18/24
04/18
17:52
04/18/24
17:52
FATE

Fate Therapeutics

$5.04 /

-0.24 (-4.55%)

, MCB

Metropolitan Bank

$33.25 /

+0.575 (+1.76%)

, ISRG

Intuitive Surgical

$372.76 /

-1.45 (-0.39%)

, KBH

KB Home

$60.40 /

-0.5 (-0.82%)

, NFLX

Netflix

$610.58 /

-3.64 (-0.59%)

, WAL

Western Alliance

$55.69 /

+0.195 (+0.35%)

, PPG

PPG

$135.12 /

+0.1 (+0.07%)

, BCML

BayCom

$20.05 /

+0.05 (+0.25%)

, CGC

Canopy Growth

$7.83 /

+1.345 (+20.74%)

Check out this evening's…

Open Full Text

Syndicate
Fate Therapeutics files to sell 3.64M shares of common stock for holders 16:03
04/18/24
04/18
16:03
04/18/24
16:03
FATE

Fate Therapeutics

$5.07 /

-0.205 (-3.89%)

 
Recommendations
Fate Therapeutics price target raised by $4 at BofA, here's why » 07:42
03/28/24
03/28
07:42
03/28/24
07:42
FATE

Fate Therapeutics

$7.35 /

+0.5 (+7.30%)

BofA analyst Tazeen Ahmad…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Syndicate
Fate Therapeutics prices 14.5M shares at $5.50 in underwritten offering » 08:46
03/19/24
03/19
08:46
03/19/24
08:46
FATE

Fate Therapeutics

$7.04 /

-0.44 (-5.88%)

Fate Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target lowered by $2 at Canaccord, here's why » 08:26
02/27/24
02/27
08:26
02/27/24
08:26
FATE

Fate Therapeutics

$6.95 /

-0.01 (-0.14%)

Canaccord analyst Bill…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target raised by $4 at Wedbush, here's why » 08:15
02/27/24
02/27
08:15
02/27/24
08:15
FATE

Fate Therapeutics

$6.95 /

-0.01 (-0.14%)

Wedbush raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target raised by $4 at Barclays, here's why » 05:30
02/27/24
02/27
05:30
02/27/24
05:30
FATE

Fate Therapeutics

$6.95 /

-0.01 (-0.14%)

Barclays raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Fly Intel: After-Hours Movers » 18:31
02/26/24
02/26
18:31
02/26/24
18:31
PUBM

PubMatic

$16.59 /

+0.175 (+1.07%)

, HIMS

Hims & Hers

$10.27 /

+0.755 (+7.93%)

, EVER

EverQuote

$17.14 /

+0.41 (+2.45%)

, TMDX

TransMedics

$77.85 /

-5.225 (-6.29%)

, ZM

Zoom Video

$63.12 /

-0.29 (-0.46%)

, TREX

Trex Company

$94.86 /

+1.01 (+1.08%)

, JANX

Janux Therapeutics

$15.14 /

-0.64 (-4.06%)

, U

Unity

$33.02 /

+1.77 (+5.66%)

, CARG

CarGurus

$23.88 /

+0.045 (+0.19%)

, SIBN

SI-Bone

$20.52 /

+0.235 (+1.16%)

, FATE

Fate Therapeutics

$6.95 /

-0.01 (-0.14%)

, WDAY

Workday

$307.27 /

+1.4 (+0.46%)

, STAA

Staar Surgical

$31.77 /

+1.12 (+3.65%)

, FIVN

Five9

$63.38 /

-0.64 (-1.00%)

, ATSG

Air Transport Services

$13.39 /

-0.57 (-4.08%)

, HLX

Helix Energy

$10.27 /

+0.105 (+1.03%)

, AAN

Aaron's

$10.45 /

-0.09 (-0.85%)

, EFC

Ellington Financial

$12.03 /

-0.135 (-1.11%)

Check out this evening's…

Open Full Text

Earnings
Fate Therapeutics reports Q4 EPS (45c), consensus (52c) » 16:04
02/26/24
02/26
16:04
02/26/24
16:04
FATE

Fate Therapeutics

$6.95 /

-0.01 (-0.14%)

Reports Q4 revenue $1.7M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:24
02/01/24
02/01
11:24
02/01/24
11:24
ITRM

Iterum Therapeutics

$1.52 /

+0.01 (+0.66%)

, RCUS

Arcus Biosciences

$15.58 /

+0.45 (+2.97%)

, FGEN

FibroGen

$1.80 /

-0.13 (-6.75%)

, FATE

Fate Therapeutics

$6.50 /

+0.35 (+5.69%)

, GNPX

Genprex

/

+

, ALRN

Aileron Therapeutics

$4.31 /

-0.105 (-2.38%)

, NBY

NovaBay

/

+

, PTN

Palatin

$3.93 /

-0.21 (-5.07%)

, ABUS

Arbutus Biopharma

$2.38 /

-0.005 (-0.21%)

, ADAP

Adaptimmune

$1.00 /

+0.035 (+3.63%)

These names in the…

Open Full Text

On The Fly
Biotech Alert: Searches spiking for these stocks today » 10:56
01/31/24
01/31
10:56
01/31/24
10:56
FGEN

FibroGen

$1.68 /

-0.03 (-1.75%)

, FATE

Fate Therapeutics

$5.81 /

+0.215 (+3.84%)

, PTN

Palatin

$4.73 /

-0.105 (-2.17%)

, NBY

NovaBay

/

+

, YMAB

Y-mAbs Therapeutics

$12.53 /

-0.02 (-0.16%)

, CKPT

Checkpoint Therapeutics

$1.98 /

+0.1 (+5.32%)

, AKBA

Akebia

$1.65 /

+0.01 (+0.61%)

, CLRB

Cellectar Biosciences

$4.06 /

+0.105 (+2.65%)

These names in the…

Open Full Text

Over a quarter ago
Hot Stocks
Fate Therapeutics announces initiation of Phase 1 trial of FT825/ONO-8250 » 08:14
01/08/24
01/08
08:14
01/08/24
08:14
FATE

Fate Therapeutics

$3.77 /

-0.07 (-1.82%)

Fate Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target lowered to $8 from $12 at Mizuho » 06:48
11/20/23
11/20
06:48
11/20/23
06:48
FATE

Fate Therapeutics

$2.44 /

+0.055 (+2.31%)

Mizuho lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target lowered to $4.50 from $5 at Stifel » 10:15
11/09/23
11/09
10:15
11/09/23
10:15
FATE

Fate Therapeutics

$2.59 /

+0.265 (+11.40%)

Stifel analyst Benjamin…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Fate Therapeutics files $300M mixed securities shelf 16:46
11/08/23
11/08
16:46
11/08/23
16:46
FATE

Fate Therapeutics

$2.33 /

+0.025 (+1.09%)

 
Earnings
Fate Therapeutics reports Q3 EPS (46c) , consensus (57c) » 16:14
11/08/23
11/08
16:14
11/08/23
16:14
FATE

Fate Therapeutics

$2.33 /

+0.025 (+1.09%)

Reports Q3 revenue $1.9M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:09
09/21/23
09/21
11:09
09/21/23
11:09
RDHL

RedHill Biopharma

/

+

, ORTX

Acquired by Kyowa Kirin

$6.94 /

-0.185 (-2.60%)

, APLT

Applied Therapeutics

$2.80 /

+0.17 (+6.46%)

, RVNC

Revance

$12.97 /

-0.18 (-1.37%)

, INCY

Incyte

$59.55 /

-0.81 (-1.34%)

, FATE

Fate Therapeutics

$2.18 /

-0.075 (-3.33%)

, GRTX

Galera Therapeutics

/

+

, BCRX

BioCryst

$7.07 /

-0.04 (-0.56%)

, APLS

Apellis

$47.16 /

-1.365 (-2.81%)

, VIR

Vir Biotechnology

$9.25 /

-0.12 (-1.28%)

These names in the…

Open Full Text

On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:09
09/20/23
09/20
11:09
09/20/23
11:09
RDHL

RedHill Biopharma

/

+

, INCY

Incyte

$60.75 /

+0.15 (+0.25%)

, FATE

Fate Therapeutics

$2.31 /

-0.05 (-2.12%)

, BCRX

BioCryst

$7.28 /

-0.36 (-4.71%)

, CABA

Cabaletta Bio

$16.55 /

-0.8 (-4.61%)

These names in the…

Open Full Text

Hot Stocks
Kura Oncology appoints Brian Powl as Chief Commercial Officer » 07:41
08/14/23
08/14
07:41
08/14/23
07:41
KURA

Kura Oncology

$11.87 /

+0.84 (+7.62%)

, FATE

Fate Therapeutics

$3.10 /

-0.175 (-5.35%)

Kura Oncology (KURA)…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target lowered to $6 from $12 at Barclays » 05:43
08/10/23
08/10
05:43
08/10/23
05:43
FATE

Fate Therapeutics

$3.39 /

-0.13 (-3.69%)

Barclays analyst Peter…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Fate Therapeutics reports Q2 EPS (54c), consensus (59c) » 16:13
08/08/23
08/08
16:13
08/08/23
16:13
FATE

Fate Therapeutics

$3.51 /

-0.03 (-0.85%)

Reports Q2 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
CytomX Therapeutics appoints Yu-Waye Chu as CMO » 08:08
07/17/23
07/17
08:08
07/17/23
08:08
CTMX

CytomX Therapeutics

$1.83 /

+0.01 (+0.55%)

, FATE

Fate Therapeutics

$4.74 /

-0.19 (-3.86%)

CytomX Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target lowered to $5.00 from $5.30 at Stifel » 10:12
05/04/23
05/04
10:12
05/04/23
10:12
FATE

Fate Therapeutics

$6.34 /

+0.025 (+0.40%)

Stifel analyst Benjamin…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Fate Therapeutics price target lowered to $5 from $8 at Cantor Fitzgerald » 07:18
05/04/23
05/04
07:18
05/04/23
07:18
FATE

Fate Therapeutics

$6.32 /

+0.405 (+6.85%)

Cantor Fitzgerald analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.